Rayaldee 30 µg
Rayaldee 30 µg is a medicine authorised by Swissmedic under authorisation number 67614. The authorisation holder is Vifor Fresenius Medical Care Renal Pharma Ltd.. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 December 2020 and the authorisation is valid without a time limit. ATC code H05BX05 places the medicine in the group Calcium homeostasis.
| Authorisation number | 67614 |
|---|---|
| Name | Rayaldee 30 µg |
| Full name | Rayaldee 30 µg, Weichkapseln retardiert |
| Authorisation holder | Vifor Fresenius Medical Care Renal Pharma Ltd. |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | H05BX05 |
| First authorisation | 22 December 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rayaldee 30 µg, Weichkapseln retardiert | B | 22 December 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | H05BX05 | 07.02.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rayaldee 30 µg authorised in Switzerland?
Yes. Rayaldee 30 µg is authorised by Swissmedic under authorisation number 67614, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rayaldee 30 µg have?
Rayaldee 30 µg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rayaldee 30 µg?
The authorisation holder is Vifor Fresenius Medical Care Renal Pharma Ltd.. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.